GlassScriptPhysician profile
David Michael Sada
NPI 1013234459
$3,531.03
in general payments reported to CMS, 2019-2025
6 companies · $887 in 2025
The $887 reported for 2025 was more than what 84% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $113 · 2021: $302 · 2022: $941 · 2023: $460 · 2024: $828 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906 · Travel and Lodging: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,906.24 |
| Travel and Lodging | $268.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,216.13 | 2020-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Obsidio, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Siemens Medical Solutions USA, INC. | $674.77 | 2021-2024 | Oncozene, Varian Cryocare Touch System, Embozene |
| Angiodynamics, INC. | $501.93 | 2022-2024 | Solero, Nanoknife |
| Trisalus Life Sciences, INC. | $52.84 | 2025 | Trinav Infusion System |
| Sirtex Medical INC | $48.15 | 2024-2025 | Lava Les (Liquid Embolic System) |
| Ethicon US, LLC | $37.21 | 2025 | Neuwave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.